| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.164.7.3596 |
| P698 | PubMed publication ID | 10725715 |
| P2093 | author name string | R Lapointe | |
| M W Taylor | |||
| P Hwu | |||
| H A Young | |||
| M X Du | |||
| M Do | |||
| P2860 | cites work | Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism | Q24336018 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 3596-3599 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation | |
| P478 | volume | 164 |
| Q27863347 | 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity |
| Q36276917 | 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis |
| Q40703952 | A modified kynurenine bioassay for quantitative determination of human interferon-gamma |
| Q38227889 | A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy |
| Q42127557 | A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells |
| Q35848222 | A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation |
| Q38941777 | ANALYSIS OF DENDRITIC CELL STIMULATION UTILIZING A MULTI-FACETED NANOPOLYMER DELIVERY SYSTEM AND THE IMMUNE MODULATOR 1-METHYL TRYPTOPHAN. |
| Q34526556 | Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure |
| Q54348683 | Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells |
| Q28547142 | An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells |
| Q53179365 | An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases |
| Q34187909 | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells |
| Q34625275 | Antigen-presenting cells and tolerance induction. |
| Q36016868 | Apicomplexan Parasite, Eimeria falciformis, Co-opts Host Tryptophan Catabolism for Life Cycle Progression in Mouse |
| Q46859827 | Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. |
| Q34418068 | Autoreactivity, dynamic tuning and selectivity |
| Q39176402 | Biological functions of Mycobacterium tuberculosis-specific CD4+T cells were impaired by tuberculosis pleural fluid |
| Q98385977 | Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine |
| Q34785580 | CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease. |
| Q56888824 | CTLA-4 Overexpression Inhibits T Cell Responses through a CD28-B7-Dependent Mechanism |
| Q58799410 | Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? |
| Q24679736 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma |
| Q30912415 | Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. |
| Q42130331 | Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity |
| Q42722774 | Characteristics of Mesenchymal Stem Cells - New Stars in Regenerative Medicine or Unrecognized Old Fellows in Autologous Regeneration? |
| Q49592881 | Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment |
| Q39356675 | Chromatographic analysis of tryptophan metabolites. |
| Q80259126 | Cinnabarinic acid generated from 3-hydroxyanthranilic acid strongly induces apoptosis in thymocytes through the generation of reactive oxygen species and the induction of caspase |
| Q35149637 | Classification of current anticancer immunotherapies |
| Q90484961 | Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond |
| Q35653808 | Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer |
| Q38852256 | Combinatorial approach to cancer immunotherapy: strength in numbers |
| Q37995939 | Combining immunotherapy and targeted therapies in cancer treatment |
| Q55003432 | Comparative metabolomics of aging in a long-lived bat: Insights into the physiology of extreme longevity. |
| Q83310909 | Comparison of the Acute Rejection Incidence Rate in Spousal Donor Transplantation Before and After Anti‐CD20 Antibody (Rituximab) Protocol as Desensitization Therapy |
| Q92040199 | Contribution of IDO to human respiratory syncytial virus infection |
| Q64243032 | Control of the Antitumor Immune Response by Cancer Metabolism |
| Q92454923 | Current Strategies to Enhance Adipose Stem Cell Function: An Update |
| Q34624242 | Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state. |
| Q27481412 | Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 Infection |
| Q37854956 | Dendritic Cells Modified by Vitamin D: Future Immunotherapy for Autoimmune Diseases |
| Q34046816 | Dendritic cells and prospects for transplantation tolerance |
| Q39712940 | Dendritic cells expressing soluble CTLA4Ig prolong antigen-specific skin graft survival |
| Q36115652 | Dendritic cells in melanoma immunotherapy |
| Q36899012 | Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege |
| Q90632243 | Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors |
| Q92493499 | Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer |
| Q34720273 | Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy |
| Q40335149 | Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines |
| Q39573791 | Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors |
| Q64081574 | Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on -Naphthaquinone-Containing Natural Product |
| Q52590808 | Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening. |
| Q37513129 | Distinct Patterns of Tryptophan Maintenance in Tissues during Kynurenine Pathway Activation in Simian Immunodeficiency Virus-Infected Macaques |
| Q27010486 | Disturbed tryptophan metabolism in cardiovascular disease |
| Q42391387 | Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine |
| Q30410002 | Early Carcinogenesis Involves the Establishment of Immune Privilege via Intrinsic and Extrinsic Regulation of Indoleamine 2,3-dioxygenase-1: Translational Implications in Cancer Immunotherapy |
| Q44088414 | Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis |
| Q45865862 | Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity |
| Q45028437 | Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNγ-regulated host pathways for the parasite development |
| Q26765777 | Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis |
| Q40615660 | Enhancement of antimicrobial effects by glucocorticoids |
| Q41956511 | Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors |
| Q46971502 | Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT. |
| Q34009281 | Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase |
| Q34768412 | Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. |
| Q28204166 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase |
| Q44628163 | Evolving immunosuppressive microenvironment during human cervical carcinogenesis |
| Q52618135 | Expression of Stat3 and indoleamine 2, 3-dioxygenase in cornea keratocytes as factor of ocular immune privilege |
| Q35835489 | Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. |
| Q30931726 | Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes |
| Q35704335 | Fat-1 transgenic cattle as a model to study the function of ω-3 fatty acids |
| Q89965568 | Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism |
| Q40315535 | Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression |
| Q26764855 | Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications |
| Q43110927 | Generation of myeloid-derived suppressor cells using prostaglandin E2 |
| Q43279107 | Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism |
| Q35156136 | HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets. |
| Q35000687 | HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. |
| Q40734971 | HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity. |
| Q37499246 | Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation |
| Q37399410 | Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis. |
| Q37416875 | High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica |
| Q41938702 | Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts |
| Q37850445 | Hodgkin Disease and the Role of the Immune System |
| Q43092676 | Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. |
| Q42985603 | Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. |
| Q27004008 | Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications |
| Q82690147 | Human periodontal ligament cells facilitate leukocyte recruitment and are influenced in their immunomodulatory function by Th17 cytokine release |
| Q35534807 | Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands |
| Q34674495 | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation |
| Q46941757 | IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells |
| Q29614752 | IDO expression by dendritic cells: tolerance and tryptophan catabolism |
| Q54347649 | IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive |
| Q36944802 | IDO-expressing regulatory dendritic cells in cancer and chronic infection |
| Q36246214 | IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells |
| Q54318303 | Identification of the indoleamine 2,3-dioxygenase nucleotide sequence in a rat liver transplant model |
| Q38680348 | Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose? |
| Q35037009 | Immune dysregulation by the rheumatoid arthritis shared epitope |
| Q36456612 | Immune modulation by mesenchymal stem cells |
| Q46480713 | Immune modulation in corneal transplantation. |
| Q44746132 | Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma |
| Q33706923 | Immunogenicity and immunomodulatory effects of the human chondrocytes, hChonJ. |
| Q35152931 | Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells--a review |
| Q42392488 | Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes |
| Q38127784 | Immunomodulatory effects of stem cells |
| Q34609461 | Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation |
| Q37144901 | Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. |
| Q26798402 | Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites |
| Q43084328 | Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer |
| Q73649349 | Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy |
| Q46393442 | Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines |
| Q46762912 | Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways |
| Q49254089 | Indoleamine 2,3-Dioxygenase (IDO) Enzyme Links Innate Immunity and Altered T-Cell Differentiation in Non-ST Segment Elevation Acute Coronary Syndrome. |
| Q36821053 | Indoleamine 2,3-Dioxygenase and Dendritic Cell Tolerogenicity |
| Q37035240 | Indoleamine 2,3-dioxygenase (IDO) is expressed at feto-placental unit throughout mouse gestation: An immunohistochemical study |
| Q51089138 | Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor |
| Q63366136 | Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells |
| Q36973676 | Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. |
| Q44761483 | Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells |
| Q37293658 | Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens |
| Q34973801 | Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy |
| Q58707093 | Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis |
| Q33339396 | Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle? |
| Q37268984 | Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. |
| Q42108021 | Indoleamine-2,3-dioxygenase enzyme expression and activity in polarized dendritic cells |
| Q58707479 | Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update |
| Q53234462 | Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells |
| Q36376598 | Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites |
| Q35060303 | Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo. |
| Q35835456 | Inhibition of experimental asthma by indoleamine 2,3-dioxygenase |
| Q35848218 | Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis |
| Q37006795 | Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection |
| Q37492248 | Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? |
| Q35139200 | Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics |
| Q45748930 | Interaction between dendritic cells and natural killer cells during pregnancy in mice. |
| Q44996678 | Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells |
| Q40210981 | Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation |
| Q58843506 | Kinetics of regulatory dendritic cells in inflammatory responses during Trypanosoma evansi infection |
| Q48122060 | Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. |
| Q34317484 | Kynurenines in the CNS: recent advances and new questions. |
| Q34939924 | LAG-3 regulates plasmacytoid dendritic cell homeostasis |
| Q39670374 | LPS-induced NF-κB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase |
| Q36728035 | Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli. |
| Q54256455 | Mechanisms of Tolerance Induction by Dendritic Cells In Vivo |
| Q28079649 | Mechanisms of mesenchymal stem/stromal cell function |
| Q44669692 | Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate |
| Q37762880 | Mesenchymal stem cells: Mechanisms of immunomodulation and homing |
| Q64088355 | Metabolic Control of Dendritic Cell Functions: Digesting Information |
| Q36075227 | Metabolic mechanisms of tumor resistance to T cell effector function |
| Q47798565 | Metabolites related to renal function, immune activation, and carbamylation are associated with muscle composition in older adults. |
| Q90287976 | Metabolomic adaptations and correlates of survival to immune checkpoint blockade |
| Q48306002 | Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences. |
| Q38234937 | Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus. |
| Q50671091 | Molecular Mechanisms of Regulatory T Cell Development and Suppressive Function |
| Q38620878 | Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy. |
| Q35059964 | Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes |
| Q35847753 | Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation |
| Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
| Q27000087 | Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship |
| Q44533646 | Natural inhibitors of indoleamine 3,5-dioxygenase induced by interferon-gamma in human neural stem cells |
| Q43884512 | Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients |
| Q48305650 | Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans. |
| Q61906267 | Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation |
| Q43083243 | Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells |
| Q37809070 | Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity |
| Q90080352 | Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma |
| Q42256888 | PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response |
| Q28392626 | Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer |
| Q39957476 | Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells |
| Q44328156 | Phenotypic characterization of human decidual macrophages |
| Q37729535 | Pleural fluid from tuberculous pleurisy inhibits the functions of T cells and the differentiation of Th1 cells via immunosuppressive factors |
| Q34242591 | Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment |
| Q35553327 | Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. |
| Q43297317 | Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis |
| Q33850216 | Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection |
| Q41078784 | Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier |
| Q36431688 | Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells |
| Q44406122 | Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE, Fc(epsilon)RI and interferon-gamma stimulation |
| Q36404125 | Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells. |
| Q42136652 | Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection |
| Q34359001 | Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains |
| Q49861299 | Regulatory T Cell Metabolism in the Hepatic Microenvironment |
| Q37855647 | Regulatory T cells in lung transplantation—an emerging concept |
| Q90706531 | Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy |
| Q92881504 | Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma |
| Q58855390 | Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy |
| Q42627529 | Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells |
| Q91728008 | Role of Macrophages in Pregnancy and Related Complications |
| Q36954185 | Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. |
| Q61959986 | Role of the Kynurenine Pathway in Stem Cell Biology |
| Q42666100 | Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography–Mass Spectrometry |
| Q40730253 | Shaping immune responses through the activation of dendritic cells' P2 receptors |
| Q82531240 | Simultaneous determination of tryptophan, kynurenine and 5-hydroxytryptamine by HPLC: Application in uremic patients undergoing hemodialysis |
| Q42212835 | Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection. |
| Q35219290 | Some interfaces of dendritic cell biology |
| Q59808506 | Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells |
| Q28069239 | Stem Cell-Derived Extracellular Vesicles and Immune-Modulation |
| Q44256981 | Study of the effect of indoleamine 2,3-dioxygenase on murine mixed lymphocyte reactions and skin allograft rejection. |
| Q37108820 | Suppression of Acute Graft-Versus-Host Response by TCDD Is Independent of the CTLA-4-IFN-γ-IDO pathway |
| Q33685980 | Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigen. |
| Q40003679 | Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase |
| Q48334858 | Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. |
| Q85932038 | Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors |
| Q26782662 | Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections |
| Q44137068 | T cell apoptosis by tryptophan catabolism |
| Q37334065 | T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase |
| Q33987835 | T regulatory cells and transplantation tolerance |
| Q38110540 | Targeting Tregs in Malignant Brain Cancer: Overcoming IDO. |
| Q58803138 | Targeting the IDO1 pathway in cancer: from bench to bedside |
| Q26775471 | Targeting the indoleamine 2,3-dioxygenase pathway in cancer |
| Q44998291 | Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG). |
| Q28275608 | The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells |
| Q26770100 | The Immunomodulatory Effects of Mesenchymal Stem Cells in Prevention or Treatment of Excessive Scars |
| Q24634995 | The Physiological Action of Picolinic Acid in the Human Brain |
| Q92394700 | The Role of Extracellular Vesicles as Paracrine Effectors in Stem Cell-Based Therapies |
| Q36980464 | The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation |
| Q38245307 | The common inflammatory etiology of depression and cognitive impairment: a therapeutic target |
| Q42408190 | The cystine/glutamate antiporter regulates indoleamine 2,3-dioxygenase protein levels and enzymatic activity in human dendritic cells |
| Q42214709 | The cystine/glutamate antiporter regulates the functional expression of indoleamine 2,3-dioxygenase in human dendritic cells |
| Q37406006 | The importance of the age factor in cancer vaccination at older age. |
| Q34657284 | The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation |
| Q38149123 | The kynurenine pathway in stem cell biology. |
| Q39825479 | The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects |
| Q35154150 | The role of indoleamine 2,3 dioxygenase in beneficial effects of stem cells in hind limb ischemia reperfusion injury |
| Q37678976 | The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs. |
| Q33779682 | The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways |
| Q41149149 | The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy |
| Q38998436 | The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas. |
| Q91826310 | The therapeutic potential of targeting tryptophan catabolism in cancer |
| Q34441123 | Therapeutic aspects of tolerance. |
| Q37413688 | Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system |
| Q34432815 | Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies |
| Q35711560 | Tolerance mechanisms and recent progress |
| Q83130087 | Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy–induced asthma |
| Q36302853 | Tolerogenic dendritic cells and their applications in transplantation |
| Q37079141 | Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy |
| Q27006866 | Trial watch: IDO inhibitors in cancer therapy |
| Q39513318 | Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators |
| Q98177668 | Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 |
| Q34400879 | Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. |
| Q28346107 | Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation |
| Q40686234 | Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division |
| Q36376561 | Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. |
| Q34472000 | Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells |
| Q34109953 | Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts |
| Q37123849 | Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment. |
| Q41855192 | Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells |
| Q38708543 | Uterine responses to early pre-attachment embryos in the domestic dog and comparisons with other domestic animal species. |
Search more.